| MJUS is an actively managed portfolio of US stocks or swap contracts related to the cannabis industry. |
FUND BASICS
| Category |
US Equities |
| Fund Sponsor |
ETFMG |
| Website |
etfmg.com/funds/mjus/ |
| Inception date |
May 12, 2021 |
| Assets (mns) |
$60 |
| Currency |
USD |
| Expense ratio |
76 bp |
| Distributions |
Quarterly |
FUND STRUCTURE
| Regulation |
Open-Ended Fund |
| Custodian |
|
| Weighting |
Proprietary |
| Index replication |
|
| Uses derivatives |
No |
| Options available |
No |
CONSTITUENT BREAKDOWN
| No. of constituents |
24 |
| Wgt avg mkt cap (mns) |
$109 |
| Large cap (>$10bn) |
0.0% |
| Mid cap ($2-10bn) |
0.0% |
| Small cap (<$2bn) |
100.0% |
| Developed mkts |
100.0% |
| Emerging mkts |
0.0% |
TOP TEN HOLDINGS
| CURALEAF HOLDINGS, INC. |
7.3 % |
| TERRASCEND CORP. |
4.7 % |
| WM TECHNOLOGY, INC. CLASS A |
3.7 % |
| INNOVATIVE INDUSTRIAL PROPERTIES I |
1.8 % |
| ASCEND WELLNESS HOLDINGS INC CL A |
1.8 % |
| CANNABIST CO HLDGS SWAP |
0.8 % |
| GROWGENERATION CORP. |
0.7 % |
Total |
20.7 % |
TOP COUNTRY EXPOSURE
 |
UNITED STATES |
13.5 % |
 |
CANADA |
4.7 % |
Standardized Annual Returns (thru February 28)
| Year-to-date |
1 year |
5 years |
10 years |
Since Incep. |
| -8.9% |
-59.0% |
-- |
-- |
-48.4% |
Market Correlations
| versus... |
Beta |
R-squared |
| S&P500 |
1.25 |
16% |
| MSCI EAFE |
1.15 |
13% |
| MSCI Emg. Mkts. |
0.93 |
9% |
Technical Indicators
| Recent close |
$0.76 |
| 30d moving avg. |
$0.81 |
| Annualized volatility |
55.3% |
| Short interest (ETF) |
0.3% |
| Relative strength (RSI) |
36 |
Liquidity measures
| Avg. volume (thou.) |
76,632 |
| Turnover |
97.3% |
| Bid/Ask (% of price) |
1.59% |
| ADV underlying (mns) |
$48 |
 |
There were no matches found with other funds under coverage. |
Content on this tab for subscribers only**
| |
2020 |
2021 |
2022 |
2023 |
2024 |
2025E |
2026E |
| Sales per share |
** |
** |
** |
** |
** |
** |
** |
| Earnings per share |
** |
** |
** |
** |
** |
** |
** |
Dividends per share  |
** |
** |
** |
** |
** |
** |
** |
| Book value per share |
** |
** |
** |
** |
** |
** |
** |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Long term EPS growth est. |
**% |
|
Debt-to-equity |
**x |
| Asset turnover |
**% |
|
Assets-to-equity |
**x |
Revision activity*
|
| *Six months ago = 100 |
Compound annual growth rates
|
Content on this tab for subscribers only
| |
2024 |
2025E |
2026E |
| Price-to-sales |
** |
** |
** |
| Price-to-earnings |
** |
** |
** |
| Price-to-cash flow |
** |
** |
** |
| Price-to-growth |
** |
** |
** |
| Price-to-book value |
** |
** |
** |
| Yield |
** |
** |
** |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
| Calculation of ALTAR Score™ |
| Avg. Return on Equity |
-7.1 |
% |
| Divided by: Fwd. P/BV |
1.6 |
x |
| Less: Expense ratio |
76 |
bp |
| Equals: ALTAR Score |
-5.1 |
% |
|
| More information on ALTAR Score™ |
|
|
|
COMPOSITE
RATING |
1.22 |
CATEGORY
AVERAGE |
1.58 |
| |
The composite rating is a weighted average of analysts'
consensus recommendations for individual ETF constituents, based on the following scale:
BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.
Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be
more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
|
|
|
|
Fundamentals